Indoco Remedies Blood-thinner Apixaban gets USFDA green flag

The products are therapeutically equivalent to the Reference Listed Drug 'Eliquis' of Bristol-Myers Squibb (BMS).

Apixaban is an anticoagulant, or blood thinner. It is used for patients with health problems caused by a blood clot.

The US market size of Apixaban Tablets is USD 11,037 million as per IMS MAT June'20 data.

Commenting on this development, Ms. Aditi Kare Panandikar, Managing Director - Indoco Remedies Ltd. said, "The receipt of approval from the US health regulator for the generic version of Apixaban Tablets is encouraging."

Read also: Indoco Remedies gets USFDA nod to Olanzapine Tablets to treat schizophrenia, bipolar disorder

Indoco develops and manufactures a wide range of pharmaceutical products for the Indian and international markets.

The Company has 9 manufacturing facilities, 6 of which are for FDFs and 3 for APIs, supported by a state-of-the-art R&D Centre and a CRO facility.

Read also: Granules India Dexmethylphenidate HCl ER capsules get USFDA approval to treat ADHD